ho comprato questo prodotto .... al buio; lo conoscete? valutazioni in merito?
XS1598567045
buy @98.2450 il12-08-17
venerdì 01-09-17 prezza 100,780
Autocallable MBRC with Extra Coupon
UL BATS LN / IMB LN / MO UN
Maturity 18Months
CCY USD
Strike 100%
KI Barrier 65% American
Autocallable Semi-annually at 100% if all Stocks are at or above the strike
Extra bonus coupon (with memory) = if all stocks are at or above the strike on the semiannual observation date, the Extra bonus coupon will be paid additionally (doubling the coupon)
Coupon = 4.50% per semester, ie 9.00% p.a.
How
• The product pays a guaranteed coupon of 4.50% (9.00% p.a.) semi-annually. In addition, the product pays an ‘extra’ coupon of 9.00% p.a. if all underlyings are at or above their initial level on each ‘autocall observation date’ and the product is redeemed early (‘autocalled’). The ‘extra’ coupon is also paid at maturity, if all underlyings are at or above 100% of their initial level.
• For example, if the product is redeemed after twelve months, the redemption is at 100% of par. In addition to the 9.00% p.a. guaranteed coupon, the investor receives the ‘extra’ coupon of 9.00% p.a. i.e. a total coupon of 18.00% (for twelve months).
• At maturity, if the three stocks have never traded at or below their individual knock-in barrier of 65% of their initial level during the life of the product, the investor receives either 1) the invested capital plus the semi-annual coupon, if at least one underlying stock closes below its initial level or 2) the invested capital, the semi-annual coupon plus the ‘extra’ coupon, if all stocks are at or above their initial level.
• If, however, during the life of the product at least one stock is at or below its individual knock-in barrier at 65% of its initial level and one or more underlying stocks close at maturity below their initial level, the investor receives an amount which takes into account the decrease of the underlying with the worst performance compared to its individual strike price, plus the guaranteed coupon.
Rational
• Major tobacco companies reacted sharply negatively after the recent US Food and Drug Administration (FDA) announcement on the US market, although the stocks subsequently somewhat recovered their initial losses. Exact details with regard to the FDA policy are not known at this point but the reduction of nicotine levels within conventional cigarettes seems to be the key goal. However, we believe it is highly unlikely that the nicotine level will be cut to non-addictive levels. We would like to emphasise that many other countries have in the past implemented maximum nicotine and tar levels without disrupting the cigarette market. For these reasons, the negative news flow should now be more than discounted in the stock prices of major tobacco companies.
• Based on this view, we currently have an autocallable multi barrier reverse convertible on British American Tobacco, Altria Group and Imperial Brands in subscription. While the first two have a ‘Buy’-rating by our equity research department, the third stock is ‘Hold’-rated.
• The product is aimed at investors who expect a neutral or mildly positive performance of the underlying stocks, but do not exclude that market corrections may occur.
Vedi l'allegato 443517
Vedi l'allegato 443518
Vedi l'allegato 443519